Adipose-Derived Mesenchymal Stem Cells, Cell-Based Therapies, and Biomaterials as New Regenerative Strategies in Plastic Surgery

Pietro Gentile

doi:10.3390/biomedicines10081875

Adipose-Derived Mesenchymal Stem Cells, Cell-Based Therapies, and Biomaterials as New Regenerative Strategies in Plastic Surgery

Biomedicines. 2022 Aug 4;10(8):1875. doi: 10.3390/biomedicines10081875.

Author

Pietro Gentile^{1

2}

Affiliations

¹ Plastic and Reconstructive Surgery, Department of Surgical Science, "Tor Vergata" University, 00133 Rome, Italy.
² Academy of International Regenerative Medicine & Surgery Societies (AIRMESS), 1201 Geneva, Switzerland.

Abstract

Adipose-derived mesenchymal stem cells (AD-MSCs), cell-based therapies, and biomaterials are interrelated terms that often go hand in hand when discussing strategies to improve tissue regeneration or to repair tissue defects [...].

Publication types

Editorial

Grants and funding

This research received no external funding.